about
Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may holdDevelopments in renal pharmacogenomics and applications in chronic kidney diseaseInhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive ratsSlowing progression of chronic kidney diseaseEmerging drugs for chronic kidney disease.Safety of ACE inhibitor therapies in patients with chronic kidney disease.Endothelin and endothelin antagonists in chronic kidney disease.Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels--a four-years prospective cohort study in TaiwanActivation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden-analysis of variations by region over the period 1991-2010.Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD.Nonapnea Sleep Disorders in Patients Younger than 65 Years Are Significantly Associated with CKD: A Nationwide Population-Based Study.Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.Pyk2 regulates H+-ATPase-mediated proton secretion in the outer medullary collecting duct via an ERK1/2 signaling pathway.Angiotensin II blockade in kidney transplant recipients.Glomerulopathy in the KK.Cg-A(y) /J mouse reflects the pathology of diabetic nephropathy.The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.Delayed progression to dialysis with early and intensive management of predialysis chronic kidney disease: a case-based approach.Dietary Energy Density, Renal Function, and Progression of Chronic Kidney Disease.Nurse practitioner care improves renal outcome in patients with CKDSevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.Differential diagnosis of glomerular disease: a systematic and inclusive approach.Proteomic urinary biomarker approach in renal disease: from discovery to implementation.New renal drug development to face chronic renal disease.Vascular endothelium in diabetes.Considering an integrated nephrology care delivery model: six principles for quality.Impact of hyperuricaemia on the chronic kidney disease-associated risk factors in a community-based population.Persistent and inducible neogenesis repopulates progenitor renin lineage cells in the kidney.Optimization of renal transfection using a renal suction-mediated transfection method in mice.A nurse-coordinated model of care versus usual care for chronic kidney disease: meta-analysis.Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?Chronic kidney disease is associated with high abdominal incisional hernia rates and wound healing disturbances.Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.AngiotensinII induces HuR shuttling by post-transcriptional regulated CyclinD1 in human mesangial cells.Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders
P2860
Q26781354-9E69EB8B-D434-49DA-BC6C-ABDD545CF3AFQ26999279-BF360A38-2FEC-4D76-8A9F-C88A63E79CEAQ28659091-B7BEF87E-F9C0-40C9-8A9F-4CD44995D966Q33873241-84F64685-4CED-4968-8348-8705F66E2257Q34420383-90AFE1CB-B135-47F2-A456-D07B6AC4A52CQ34434606-C81C4F66-F186-4554-A461-2A0EA33D5B9CQ34437692-32F50C60-2AD8-4DC1-BFAB-6445F782EBC1Q34680658-70CC47E4-98F5-4487-9EF9-3C72C58AACF9Q35045451-C9F327DE-37F2-4C29-9727-238A4D412E19Q35182125-BD09FEDE-896C-4B4D-A4D9-8FBAB6F9FB36Q35452354-8761E2CC-033E-4CF9-89D5-38E557EB6884Q35612465-63904533-4B3D-4F96-ACD3-800C08308121Q35806577-0D712D4E-4315-44ED-A4DA-EEDD1A70A6D2Q36168673-22FA2FB4-AEA2-4AFB-B6AA-9EF9A11738C5Q36455829-C9D53B9A-7FD0-4F76-AB10-14279B0D49A0Q36574775-C7C92713-6D9E-4E89-8D69-4504F9520CFEQ36848587-AE25E9E9-CB0A-4193-86A0-7B89058C7ABCQ37147122-1F2C7BCD-DEF0-4130-ABE4-4CC0846885FFQ37256525-4A9647E5-8271-4D23-801C-356CB6C9BBABQ37369930-D0CDA5E9-AA78-4FC7-BCA5-64F6768DAB42Q37524066-F9A02322-7D49-4F5C-BA9C-BA615EAFC867Q37567574-D3285EF9-8352-4EAA-A345-CD5FD79F0103Q37624685-4A5201CE-3BC0-4E3A-8821-FE51A89B1A5FQ38139836-FA46B2FD-FC6D-4CCE-BFCC-8B8F390437F9Q38196316-EC8A3E24-A9AF-4DFF-B57B-12EF055A1959Q38246640-54D78440-28C8-4604-AEB5-5E745FFA4755Q39010377-1BB66B73-3CE8-4BBA-A31A-F967303A797AQ41099325-A6B79D8C-89A4-4883-940B-2469024367D3Q41479624-F0FD5D72-4978-4BC2-8662-A1CCFB6AD389Q45062891-37814671-96CC-4A71-B756-6C53C0312DC7Q45879407-3C6993D3-DD67-4ECB-83C9-1BD5B10B595FQ47638571-FAE50F16-0AF4-4733-93F3-C26869E57E79Q50102454-F6DC6C5E-81EF-4070-96E2-DE2FAFA01C7FQ50768670-81D201FA-D946-4026-9E07-01E6A2E6F38EQ51100638-3D8249FA-B62C-4285-B385-8E26765B626EQ51524633-9C138A63-FC96-4241-8F94-A4AB81237FFEQ51741240-DE29A4AF-36B0-419C-ADB8-D75B14593EFAQ58492144-E27B9A84-3F58-4770-8082-50055113D4CC
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Treatment of chronic kidney disease
@ast
Treatment of chronic kidney disease
@en
Treatment of chronic kidney disease
@nl
type
label
Treatment of chronic kidney disease
@ast
Treatment of chronic kidney disease
@en
Treatment of chronic kidney disease
@nl
prefLabel
Treatment of chronic kidney disease
@ast
Treatment of chronic kidney disease
@en
Treatment of chronic kidney disease
@nl
P2093
P3181
P356
P1433
P1476
Treatment of chronic kidney disease
@en
P2093
Carolyn Bauer
Jeffrey M. Turner
Matthew K. Abramowitz
Michal L. Melamed
Thomas H. Hostetter
P2888
P304
P3181
P356
10.1038/KI.2011.380
P407
P577
2012-02-01T00:00:00Z
P5875
P6179
1020742737